All the hand-wringing this week over whether or not the U.S. economy has fallen into recession lacked an important consideration: What if the measure of GDP we’re all focused on is itself massively flawed?
It’s a heretical question, because there’s a ‘GDP complex’ at work here.
There’s an entire apparatus — economists, bankers, government officials, and prognosticators — of folks whose livelihoods are predicated on measuring GDP, maintained as the be-all and end-all method for measuring a country’s economic, or even societal, health.
And, of course, GDP growth is never quite ‘right.’ It’s either too fast or slow, and these parties are always ready to help fix things.
Leaving aside the experts’ deficiencies in predicting or fixing, by fixating on GDP this august group often misses items like sustainability and quality of life.
“[GDP] is a shortcut, it’s not comprehensive enough,” economist Mohamed El-Erian told me recently. “It’s a cognitive trap. We’ve all gotten used to measuring things by GDP, and we’re having a huge problem getting out of that. Also the nature of GDP growth is important. Is it inclusive? It’s a useful measure, but it is just a tiny perspective into an economy.”
“What we are now concerned about has to do with the quality of the output of our economy, the quality of the food we eat, the quality of the air we breathe,” says David Pilling, author of the 2018 book “The Growth Delusion,” which explored our societal obsession with economic growth. “The only way of increasing the GDP of Beethoven’s Ninth Symphony, is to play it twice the speed so you can have more of it.”
Before you accuse me of going crunchy granola on you, know that we do look beyond GDP in some instances.
Example: The fastest way for a factory to grow is to keep costs as low as possible which means dumping toxic waste in the nearby river. Sure we don’t do that today, but we could do much more.
Questioning GDP, though, begs an even more fundamental question: Does an economy need to grow? It’s a point that’s been debated at least as far back as John Stuart Mill in the mid 19th century. More recently Herman Daly, a former senior economist for the World Bank, has been a leading voice in the ‘steady state’ movement, which he spoke to in a recent New York Times interview.
There’s a ton of interesting stuff in there from Daly, like: “Earth is not expanding. We don’t get new materials, and we don’t export stuff to space. So you have a steady-state Earth, and if you don’t recognize that, well, there’s an education problem.”
Holistic socio-economic models haven’t been widely adopted of course, with some notable exceptions.
In 1972, Bhutan abandoned GDP as its measure of economic progress and replaced it with…happiness. The Guardian reports: “[Bhutan] has championed a new approach to development, which measures prosperity through formal principles of gross national happiness (GNH) and the spiritual, physical, social and environmental health of its citizens and natural environment.”
Much has been written about the Bhutanese experiment (here and here) and there are shortcomings, but even its critics have to acknowledge its successes. New Zealand, for its part, now has a “Wellbeing Budget.”
Vox notes: “To Prime Minister Jacinda Ardern, the purpose of government spending is to ensure citizens’ health and life satisfaction, and that — not wealth or economic growth — is the metric by which a country’s progress should be measured. GDP alone, she said, ‘does not guarantee improvement to our living standards’ and nor does it ‘take into account who benefits and who is left out.'”
“The really important thing which New Zealand understands is that subjective well-being data can be used to unlock the policy situation,” says John Helliwell, professor emeritus at the University of British Columbia.
Some U.S. economists scoff Bhutan and New Zealand (or is it Aotearoa?): “Fringe economies,” kind of stuff. These same dismal scientists disparage Italy, Spain, and France too, which to my mind have budgeted — inadvertently to a degree — along these lines for centuries. And as I pointed out, they’re decent places to live too.
GDP is hardly a hallowed metric, nor is it infallible.
On the first count, remember that up until 1991, we used to use GNP (gross national product) to measure the economy. As for fallibility, look to Ireland and its “Leprechaun economic” episode — a phrase coined by Paul Krugman after the country reported GDP growth of 26.3% in 2015, the result of massive tax sheltering schemes by multinational companies, in particular, it seems, Apple.
Two years later, Ireland replaced GDP with Modified GNI (Gross National Income).
But the “GDP complex” doesn’t have to resort to such extremes to win at this game.
Fixing low or non-growing GDP through fiscal policy (cutting taxes) and monetary policy (cutting interest rates) disproportionately helps the shareholder class, which includes the aforementioned economists, bankers, government officials, and prognosticators. Those tools do not directly address life expectancy, infant mortality, drug addiction, murder, and suicide rates. No country obsesses more over GDP data than the U.S., and yet our quality of life relative to other countries (see here and here) is a shocking embarrassment.
“GDP is weighted toward the people whose incomes are higher. It’s their experience that is dominating the GDP,” says Richard Easterlin, professor emeritus of economics at USC. “In the case of happiness, it doesn’t matter whether you’re a shareholder, or farmer. Each of you counts the same.”
Is it possible to have strong GDP growth and high quality of life across a society?
Some might argue that we used to in the United States — though huge portions of our population had a paucity of civil rights back in those “good old days.” Singapore perhaps, but it also has limited civil liberties.
So, which would you rather have: strong GDP growth and poor quality of life for a majority of citizens, or find another measure that helps raise all ships?
I think I’m on board with the latter.
—
This article was featured in a Saturday edition of the Morning Brief on July, 30, 2022. Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET. Subscribe
Follow Andy Serwer, editor-in-chief of Yahoo Finance, on Twitter: @serwer
Click here for the latest economic news and economic indicators to help you in your investing decisions
Read the latest financial and business news from Yahoo Finance
Download the Yahoo Finance app for Apple or Android
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube
Yahoo Finance's Pras Subramanian breaks down Ford earnings.
Apple's iPhone sales fell short of analysts' expectations in Q1.
Yahoo Finance's Brad Smith breaks down headline numbers from Google parent company Alphabet's earnings.
When Cathie Wood speaks, people listen. The chief executive of Ark Investment Management has had a far-from-perfect record when it comes to her investment choices — not to mention not exactly flattering feedback from CNBC's Jim Cramer. When asked what stock Wood would choose she won a million dollar lottery and was forced to choose a stock for ten years, Wood's pick was just as disruptive as her reputation.
Shares of apparel company Hanesbrands (NYSE: HBI) dropped like a rock on Thursday after the company provided lackluster financial guidance and announced some substantial pivots to management's priorities. As of 11:40 a.m. ET, Hanesbrands stock was down 23% — particularly painful, considering the market is soaring today. On one hand, fourth-quarter revenue of $1.47 billion beat guidance from Hanesbrands' management.
Two major automakers want to put more fuel cell vehicles on the road — and Plug Power investors took note.
There's more evidence now favoring medical marijuana legalization. But medical marijuana is already legal in most states.
Amazon reported its Q4 2022 earnings on Feb. 2.
Shares of Carnival (NYSE: CCL) jumped 34.2% in January compared to where it closed out 2022, according to data provided by S&P Global Market Intelligence, as the cruise line operator, which is working to return to full capacity, said it would raise its prices. The increase in certain rates suggests there is still strong, latent demand for ocean-going travel that bodes well for the cruise company's profitability. Revenue per passenger cruise days for the period was up sequentially from the third quarter and ahead of 2019 even though occupancy was a full 19 percentage points lower than three years ago.
Leading iBuyer Opendoor (NASDAQ: OPEN) was having an excellent day on Thursday. As of 3 p.m. EST, the real estate disruptor's stock had risen by 14% for the day and has now more than tripled from its 52-week low in just over a month. There isn't any company-specific news driving the news higher, but there has been a surge in optimism for the real estate market in general.
Google parent Alphabet reported earnings below analysts' expectations on Thursday.
Dividend stocks are a great way to mitigate downside risk, hedge against inflation, and generate reliable levels of passive income. Closed-end funds, real estate investment trusts (REITs), and some actively managed diversified holding companies are purpose-built to return an outsize portion of cash flows to shareholders via regular distributions. Arbor Realty Trust (NYSE: ABR) is a REIT with a current annualized yield of 10.75%.
Tesla might be the loudest in the room when talking about driverless cars, but Mercedes claims it just beat Tesla at its own game. With a starting price at $105,450, it was ranked eighth for luxury electric vehicles (EVs) by Car and Driver, behind Lucid's Air, several of the Porsches, the Tesla model S and the BMW i7. While folks fawn over the Cyber Truck and the latest new EV, Mercedes has been hard at work developing the inside of its cars — specifically, its autonomous driving capabilities.
On any list of biotech plays that might multiply in value in a relatively short period, Cassava Sciences (NASDAQ: SAVA) is likely to be near the top of the list. It's exploring whether its drug called simufilam is safe and effective to treat early-stage Alzheimer's disease, though its clinical trials have (so far) shed little light on the issue. The biggest reason to sell Cassava stock: After an open-label phase 2 clinical trial of simufilam, the market reacted quite negatively to the release of new data that management spun as being positive.
Yahoo Finance Live's Seana Smith breaks down Apple's weaker-than-expected first quarter earnings.
Have a question about working with your financial adviser or looking to hire a new one? Email picks@marketwatch.com.
Change doesn't have to be bad.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Following the company's previous earnings release, Cramer apologized to his audience, saying that his trust in Meta's management team was "ill-advised" and that his bullish hubris was "extraordinary, and I apologize."
Yahoo Finance Live examines Hanesbrands shares following losing dividends and consumer pivots away from the innerwear staple.